Trial Profile
Effects of Saxagliptin on Adipose Tissue Inflammation in Humans
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Saxagliptin (Primary)
- Indications Obesity
- Focus Pharmacodynamics
- 11 Mar 2020 Status changed from active, no longer recruiting to completed.
- 25 Mar 2019 Planned End Date changed from 1 Jun 2017 to 1 Mar 2020.
- 25 Mar 2019 Planned primary completion date changed from 1 Jun 2016 to 1 Dec 2019.